380 related articles for article (PubMed ID: 19026250)
1. Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
Cipriani A; Furukawa TA; Geddes JR; Malvini L; Signoretti A; McGuire H; Churchill R; Nakagawa A; Barbui C;
J Clin Psychiatry; 2008 Nov; 69(11):1732-42. PubMed ID: 19026250
[TBL] [Abstract][Full Text] [Related]
2. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2010 Apr; (4):CD006117. PubMed ID: 20393946
[TBL] [Abstract][Full Text] [Related]
3. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2010 Jan; (1):CD006117. PubMed ID: 20091586
[TBL] [Abstract][Full Text] [Related]
4. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2009 Apr; (2):CD006117. PubMed ID: 19370626
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
6. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
8. Paroxetine versus other anti-depressive agents for depression.
Purgato M; Papola D; Gastaldon C; Trespidi C; Magni LR; Rizzo C; Furukawa TA; Watanabe N; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006531. PubMed ID: 24696195
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
J Clin Psychiatry; 2008 Sep; 69(9):1404-15. PubMed ID: 19193341
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
11. Milnacipran versus other antidepressive agents for depression.
Nakagawa A; Watanabe N; Omori IM; Barbui C; Cipriani A; McGuire H; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD006529. PubMed ID: 19588396
[TBL] [Abstract][Full Text] [Related]
12. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine versus other types of pharmacotherapy for depression.
Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
[TBL] [Abstract][Full Text] [Related]
14. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
CNS Drugs; 2010 Jan; 24(1):35-53. PubMed ID: 20030418
[TBL] [Abstract][Full Text] [Related]
15. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants versus placebo for panic disorder in adults.
Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
[TBL] [Abstract][Full Text] [Related]
17. Citalopram versus other anti-depressive agents for depression.
Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C
Cochrane Database Syst Rev; 2012 Jul; 7(7):CD006534. PubMed ID: 22786497
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants versus placebo for depression in primary care.
Arroll B; Elley CR; Fishman T; Goodyear-Smith FA; Kenealy T; Blashki G; Kerse N; Macgillivray S
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007954. PubMed ID: 19588448
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants plus benzodiazepines for adults with major depression.
Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]